Protease inhibitor therapy-associated lipodystrophy, hypertriglyceridaemia and diabetes mellitus.
Paparizos
V A
VA
Kyriakis
K P
KP
Botsis
C
C
Papastamopoulos
V
V
Hadjivassiliou
M
M
Stavrianeas
N G
NG
D000328:Adult; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors